Rocket Lab scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
The Discounted Cash Flow (DCF) model estimates a company’s intrinsic value by projecting its future free cash flows and discounting them back to today’s dollars. This approach is useful for growth stocks like Rocket Lab because near-term profits might not fully reflect the business’s long-term potential.
Currently, Rocket Lab’s Free Cash Flow (FCF) stands at negative $208.5 million. Analysts only forecast FCF for up to five years, with $58.6 million projected by the end of 2027. Further estimates are extrapolated by Simply Wall St’s model. Over the next decade, Rocket Lab’s annual FCF is projected to grow sharply, moving from negative figures today to more than $585 million by 2035. All cash flows are reported in US dollars.
Based on these projections, Rocket Lab’s estimated intrinsic value per share is $17.76. However, with the current share price far above this level, the DCF model implies Rocket Lab is 218.5% overvalued. Even accounting for aggressive growth assumptions, the stock trades much higher than its calculated fair value.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Rocket Lab may be overvalued by 218.5%. Discover 842 undervalued stocks or create your own screener to find better value opportunities.
The Price-to-Book (PB) ratio is traditionally used for valuing companies where profits are not yet consistent or positive. This makes it a useful option for high-growth firms like Rocket Lab. This multiple compares a company’s market value to its net assets, helping investors understand how much they are paying for the underlying value of the business.
Growth expectations and the risk profile of a company can push its PB ratio higher than average if markets believe future prospects are strong. However, an extremely high PB can also signal over-optimism or excessive risk-taking compared to typical industry valuations.
Currently, Rocket Lab trades at a PB ratio of 39.77x, which is much higher than both the Aerospace & Defense industry average of 3.64x and the peer group average of 10.79x. Such a significant premium might appear concerning at first glance. Simply Wall St’s proprietary “Fair Ratio” seeks to address this by factoring in Rocket Lab’s specific growth outlook, profit margins, risk, market cap, and industry positioning. Unlike a basic industry or peer comparison, the Fair Ratio offers a more holistic, company-tailored benchmark for valuation.
By comparing Rocket Lab’s actual PB ratio to the Fair Ratio, we can form a clearer view of its valuation. In this case, Rocket Lab’s PB ratio is well above what would be considered fair, suggesting the stock is priced for extremely optimistic outcomes.
Result: OVERVALUED
PB ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1409 companies where insiders are betting big on explosive growth.
Earlier we mentioned there is an even better way to understand valuation, so let us introduce you to Narratives. A Narrative is a powerful yet simple framework that allows you to tell the story behind a company using your own assumptions. This links your perspective on Rocket Lab’s business drivers, future revenue, profit margins, and fair value to build a clear, forward-looking forecast. With Narratives on Simply Wall St’s Community page, you can easily map your outlook for Rocket Lab, compare your Fair Value to the current Price to decide if it is time to buy or sell, and see your Narrative update dynamically whenever new information or earnings are released.
Narratives help investors move beyond static metrics by making it easy to model and test different scenarios, so you can see how changes in growth rates, margins, or industry news impact your investment thesis in real time.
For example, one Rocket Lab investor might forecast aggressive revenue growth, high margins, and set a Fair Value as high as $58.67, while a more cautious investor, concerned about risks and execution, may believe the Fair Value is closer to $20. Narratives make these perspectives visible and actionable, empowering you to invest with confidence and insight, rather than relying solely on headline numbers.
For Rocket Lab, however, we'll make it really easy for you with previews of two leading Rocket Lab Narratives:
Fair Value: $58.67
Current Price Discount: -3.6%
Forecast Revenue Growth: 37.36%
Fair Value: $31.72
Current Price Premium: 78.5%
Forecast Revenue Growth: 30.0%
Do you think there's more to the story for Rocket Lab? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com